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Background: Currently, American Diabetes Association (ADA) guidelines suggest statin use among individuals with diabetes mellitus (DM) >40 
years old. Coronary artery calcium (CAC) is a very sensitive surrogate of CAD and has been shown to be an independent predictor of mortality and 
cardiac events. In this study, we aimed to assess the prevalence and severity of CAC between DM and non-DM 40 years old or younger.
Methods: The charts of 3711 patients 40 years old or younger who had undergone CAC scoring at our center were reviewed. Their clinical and 
demographic data were collected. The cohort was divided into diabetics and non-diabetics. CAC score (CACS) was categorized into CAC 0= normal, 
1-99 low, 100-399 intermediate and >400 severe; and statistical analysis was performed.
Results: The study population consisted of 4% diabetics (n=130) and 54% males with a mean age 36±4 years. More than half, or 52% of diabetics 
had a CAC score between 1-99 versus only 24% of non diabetics (p<0.0001). In addition, 12% of diabetics vs. 2% of non-diabetics had a CAC score 
of 100-399 (p<0.0001). In unadjusted analyses, DM and a CAC score 1-99 had an OR of 6.22 (95% CI: 3.52-10.98, p<0.0001). After taking into 
account age, gender, dyslipidemia, hypertension, and smoking, the presence of DM in individuals 40 years of age or younger was associated with a 4 
fold higher risk of a CAC score of 1-99 (OR: 4.00. 95% CI: 2.17-7.33, p<0.0001).
Conclusion: Our study demonstrated that more than half of young patients with DM have detectable coronary atherosclerosis and are at 4-6 
fold higher risk for presence of significant CAC. ADA guidelines should consider statin use in those 40 years old or younger who exhibit subclinical 
atherosclerosis to reduce future CVD events in this vulnerable population. CAC testing can potentially identify diabetic individuals who may likely 
benefit from aggressive primary preventive strategies.
